Literature DB >> 6751451

Evidence for carriage of silver by sulphadimidine: haemolysis of human erythrocytes.

P M Ballinger, B S Brown, M M Griffin, F S Steven.   

Abstract

1 Human erythrocytes suspended in isotonic saline haemolyse in the presence of both Ag+ ions and sulphadimidine. 2 Neither Ag+ ions nor sulphadimidine on their own will haemolyse erythrocytes suspended in isotonic saline. 3 At constant Ag+ ion concentration the degree of haemolysis of saline-suspended erythrocytes depends upon the concentration of sulphadimidine. 4 Human erythrocytes suspended in isotonic sucrose (chloride-free) haemolyse in the presence of Ag+ ions. 5 Sulphadimidine in chloride-free sucrose competes with erythrocytes for Ag+ ions resulting in stoichiometric protection of the erythrocytes from the haemolytic action of Ag+ ions. 6 Haemolysis occurs when each erythrocyte receives approximately 1.2 X 10(9) Ag+ ions whether suspended in saline or sucrose. 7 Sulphadimidine acts as a carrier for Ag+ ions and so prevents their precipitation as AgCl when erythrocytes are suspended in saline.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751451      PMCID: PMC2044639          DOI: 10.1111/j.1476-5381.1982.tb09279.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Binding of the cardiac glycoside ouabain to intact cells.

Authors:  P F Baker; J S Willis
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

2.  Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.

Authors:  C L Fox
Journal:  Arch Surg       Date:  1968-02

3.  Use of silver sulphadiazine in the treatment of burns at Royal Perth Hospital.

Authors:  I A McDougall
Journal:  Med J Aust       Date:  1972-05-06       Impact factor: 7.738

4.  The correlation between ouabain binding and potassium pump inhibition in human and sheep erythrocytes.

Authors:  C H Joiner; P K Lauf
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

5.  Evidence for the carriage of silver by sulphadimidine: inhibition of proteolytic enzymes.

Authors:  P M Ballinger; M M Griffin; S Itzhaki; F S Stevens
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

  5 in total
  2 in total

1.  Evidence for the carriage of silver by sulphadimidine: inhibition of proteolytic enzymes.

Authors:  P M Ballinger; M M Griffin; S Itzhaki; F S Stevens
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

2.  Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation.

Authors:  Julie Laloy; Valentine Minet; Lutfiye Alpan; François Mullier; Sonja Beken; Olivier Toussaint; Stéphane Lucas; Jean-Michel Dogné
Journal:  Nanobiomedicine (Rij)       Date:  2014-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.